ARTICLE
18 August 2016

DEA Buzzkill: Marijuana Remains Illegal Under Federal Law

SS
Seyfarth Shaw LLP
Contributor
With more than 900 lawyers across 18 offices, Seyfarth Shaw LLP provides advisory, litigation, and transactional legal services to clients worldwide. Our high-caliber legal representation and advanced delivery capabilities allow us to take on our clients’ unique challenges and opportunities-no matter the scale or complexity. Whether navigating complex litigation, negotiating transformational deals, or advising on cross-border projects, our attorneys achieve exceptional legal outcomes. Our drive for excellence leads us to seek out better ways to work with our clients and each other. We have been first-to-market on many legal service delivery innovations-and we continue to break new ground with our clients every day. This long history of excellence and innovation has created a culture with a sense of purpose and belonging for all. In turn, our culture drives our commitment to the growth of our clients, the diversity of our people, and the resilience of our workforce.
Yesterday sparks flew as word was out that the DEA would be making some important announcements relating to the treatment of marijuana as a Schedule 1 substance under the CSA.
United States Food, Drugs, Healthcare, Life Sciences
To print this article, all you need is to be registered or login on Mondaq.com.

Yesterday sparks flew as word was out that the DEA would be making some important announcements relating to the treatment of marijuana as a Schedule 1 substance under the Controlled Substances Act (CSA).

Today, the excitement died down as the DEA issued a 180-page denial (inclusive of attachments; the actual denial is only three pages long) of a petition to initiate rulemaking proceedings to reschedule marijuana, filed by a Mr. Bryan Krumm in December 2009.

Mr. Krumm's petition requested that marijuana be removed from Schedule I of the CSA claiming that: 1) marijuana has accepted medical use in the U.S.; 2) studies have shown that smoked marijuana has proven safe and effective; 3) marijuana is safe for use under medical supervision; and 4) marijuana does not have the abuse potential for placement in Schedule I.

After gathering all necessary data, DEA involved the Department of Health and Human Services (HHS), which then conducted its own scientific and medical evaluation into Mr. Krumm's assertions. HHS concluded that marijuana does have a potential for abuse, does not have an accepted medical use in this country, and does not have an acceptable level of safety for use even under the care of a medical professional.  For now, marijuana remains a Schedule I drug under the CSA, and therefore is still illegal under federal law.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

ARTICLE
18 August 2016

DEA Buzzkill: Marijuana Remains Illegal Under Federal Law

United States Food, Drugs, Healthcare, Life Sciences
Contributor
With more than 900 lawyers across 18 offices, Seyfarth Shaw LLP provides advisory, litigation, and transactional legal services to clients worldwide. Our high-caliber legal representation and advanced delivery capabilities allow us to take on our clients’ unique challenges and opportunities-no matter the scale or complexity. Whether navigating complex litigation, negotiating transformational deals, or advising on cross-border projects, our attorneys achieve exceptional legal outcomes. Our drive for excellence leads us to seek out better ways to work with our clients and each other. We have been first-to-market on many legal service delivery innovations-and we continue to break new ground with our clients every day. This long history of excellence and innovation has created a culture with a sense of purpose and belonging for all. In turn, our culture drives our commitment to the growth of our clients, the diversity of our people, and the resilience of our workforce.
See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More